Literature DB >> 5217785

Metabolic and therapeutic effects of hydroxyurea in chronic myelogenous leukemia.

B J Kennedy, J W Yarbro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5217785

Source DB:  PubMed          Journal:  Trans Assoc Am Physicians        ISSN： 0066-9458


× No keyword cloud information.
  3 in total

1.  The rationale for using hydroxycarbamide in the treatment of sickle cell disease.

Authors:  David C Rees
Journal:  Haematologica       Date:  2011-04       Impact factor: 9.941

Review 2.  Cancer chemotherapy: past, present, and future--Part I.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1984-08       Impact factor: 1.798

Review 3.  Chronic myeloid leukemia: reminiscences and dreams.

Authors:  Tariq I Mughal; Jerald P Radich; Michael W Deininger; Jane F Apperley; Timothy P Hughes; Christine J Harrison; Carlo Gambacorti-Passerini; Giuseppe Saglio; Jorge Cortes; George Q Daley
Journal:  Haematologica       Date:  2016-05       Impact factor: 9.941
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.